Our results imply that the presence of amyloid may influence the spatial or asymmetric distribution of DAT availability in the PD and DLD groups, and thus, the prevalence of amyloid positivity may contribute to the different results in previous studies. Here, SLC6A3 is linked to Parkinson disease.